Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses
Traumatic spinal cord injury (SCI) is a cause of significant morbidity, often resulting in long-term disability. We aimed to compare outcomes after riluzole versus patients who received placebo or standard of care with no specific intervention. MEDLINE, Embase, Scopus, and Cochrane Library database...
Saved in:
| Main Authors: | Luke J. Weisbrod, Thomas T. Nilles-Melchert, Judith R. Bergjord, Daniel L. Surdell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mary Ann Liebert
2024-11-01
|
| Series: | Neurotrauma Reports |
| Subjects: | |
| Online Access: | https://www.liebertpub.com/doi/10.1089/neur.2023.0114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Granulocyte-Colony Stimulating Factor Improves Neurological and Functional Outcomes in Patients With Traumatic Incomplete Spinal Cord Injuries: A Systematic Review With Meta-Analyses
by: Luke J. Weisbrod, et al.
Published: (2024-11-01) -
Riluzole’s role in treatment of spinal cord injuries – overview of studies on animals and humans
by: Wenancjusz Stołowski, et al.
Published: (2025-05-01) -
The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic techniqueResearch in context
by: Michael G. Fehlings, et al.
Published: (2025-08-01) -
Pathobiology of traumatic spinal cord injury: an overview
by: William A. Florez-Perdomo, et al.
Published: (2024-05-01) -
Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery
by: Cristian Gonzalez-Ruiz, et al.
Published: (2025-06-01)